Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panitumumab in Platinum-resistant Advanced Head and Neck Squamous Cancer
NCT02643056Phase 2Completed
- Sponsor
- Southern Europe New Drug Organization
- Start
- Jan 2011
- Primary completion
- Dec 2015
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 2 trial of panitumumab in head and neck squamous cell carcinoma (HNSCC), sponsored by Southern Europe New Drug Organization. Started Jan 2011; status: completed.
02
Drugs
panitumumab
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT02643056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02643056.